ANI Pharmaceuticals, Inc.
ANIP
$70.70
$0.470.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 24.71M | 29.49M | 27.49M | 26.62M | 8.55M |
| Total Depreciation and Amortization | 19.64M | 20.92M | 22.61M | 22.63M | 23.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.92M | 7.58M | 7.12M | 12.64M | 7.75M |
| Change in Net Operating Assets | 6.40M | 382.00K | -26.85M | -17.84M | 36.24M |
| Cash from Operations | 56.67M | 58.38M | 30.37M | 44.06M | 75.81M |
| Capital Expenditure | -3.05M | -6.07M | -1.24M | -6.10M | -4.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -5.25M | -159.00K | -60.00K | -2.90M |
| Cash from Investing | -3.05M | -11.32M | -1.40M | -6.16M | -6.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.06M | -4.06M | -4.06M | -2.03M | -2.03M |
| Issuance of Common Stock | 308.00K | 2.20M | 38.00K | 9.79M | 1.24M |
| Repurchase of Common Stock | -813.00K | -19.76M | -611.00K | -1.04M | -551.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 0.00 | -344.00K | -407.00K |
| Other Financing Activities | -80.00K | -- | 0.00 | -26.00K | -- |
| Cash from Financing | -4.65M | -21.62M | -4.64M | 6.35M | -1.75M |
| Foreign Exchange rate Adjustments | 67.00K | 156.00K | -1.35M | 576.00K | 841.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.04M | 25.59M | 22.98M | 44.81M | 68.00M |